Reports

Drug name	NICE TAs	Comments
Streptokinase injection	TA52 - Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction	Hospital use only
Streptozocin injection		QEHB use only
Sucroferric oxyhydride		Under review.
Sucroferric oxyhydroxide (Velphoro)		2nd or 3rd line agent. Specialist use.
Sugammadex		Restricted use as per protocol
Sulfasalazine#10.1		ESCA
Sulindac tablets		Polyhydramnios (women only)
Sulpiride tablets		ESCA
Sunitinib capsules	TA178 - Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma (Negative TA) TA169 - Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma TA179 - Sunitinib for the treatment of gastrointestinal stromal tumours TA449 - Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease	Hospital use only
Tacrolimus 0.1% w/w in OrabaseTM		Unlicensed special

University Hospitals Birmingham NHS Foundation Trust